The latest molecular research have provided quite a few insights in to the processes that govern the event and progression of CLL, which include lots of novel mutated genes clustered in different functional pathways. The CLL epigenome is reprogrammed through the modulation of regulatory locations that show up de novo in the condition, Whilst other